These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 7968028)

  • 21. Role of tigecycline in the control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit.
    Jamal W; Salama M; Dehrab N; Al Hashem G; Shahin M; Rotimi VO
    J Hosp Infect; 2009 Jul; 72(3):234-42. PubMed ID: 19493588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Considerations in control and treatment of nosocomial infections due to multidrug-resistant Acinetobacter baumannii.
    Urban C; Segal-Maurer S; Rahal JJ
    Clin Infect Dis; 2003 May; 36(10):1268-74. PubMed ID: 12746772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nosocomial multi-drug resistant Acinetobacter baumannii bloodstream infection: risk factors and outcome with ampicillin-sulbactam treatment.
    Smolyakov R; Borer A; Riesenberg K; Schlaeffer F; Alkan M; Porath A; Rimar D; Almog Y; Gilad J
    J Hosp Infect; 2003 May; 54(1):32-8. PubMed ID: 12767844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emergence in Taiwan of novel imipenem-resistant Acinetobacter baumannii ST455 causing bloodstream infection in critical patients.
    Lee HY; Huang CW; Chen CL; Wang YH; Chang CJ; Chiu CH
    J Microbiol Immunol Infect; 2015 Dec; 48(6):588-96. PubMed ID: 26055692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Susceptibility of the Acinetobacter calcoaceticus-A. baumannii complex to imipenem, meropenem, sulbactam and colistin.
    Dueñas Díez AI; Bratos Pérez MA; Eiros Bouza JM; Almaraz Gómez A; Gutiérrez Rodríguez P; Miguel Gómez MA; Orduña Domingo A; Rodríguez-Torres A
    Int J Antimicrob Agents; 2004 May; 23(5):487-93. PubMed ID: 15120728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii.
    Corbella X; Ariza J; Ardanuy C; Vuelta M; Tubau F; Sora M; Pujol M; Gudiol F
    J Antimicrob Chemother; 1998 Dec; 42(6):793-802. PubMed ID: 10052904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eradication of multi-drug resistant Acinetobacter from an intensive care unit.
    Podnos YD; Cinat ME; Wilson SE; Cooke J; Gornick W; Thrupp LD
    Surg Infect (Larchmt); 2001; 2(4):297-301. PubMed ID: 12593705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross-transmission of multidrug-resistant Acinetobacter baumannii clonal strains causing episodes of sepsis in a trauma intensive care unit.
    Markogiannakis A; Fildisis G; Tsiplakou S; Ikonomidis A; Koutsoukou A; Pournaras S; Manolis EN; Baltopoulos G; Tsakris A
    Infect Control Hosp Epidemiol; 2008 May; 29(5):410-7. PubMed ID: 18419362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Molecular characterization of beta-lactamase-associated resistance in Acinetobacter baumannii strains isolated from clinical samples].
    Keskin H; Tekeli A; Dolapci İ; Öcal D
    Mikrobiyol Bul; 2014 Jul; 48(3):365-76. PubMed ID: 25052103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of resistance to ciprofloxacin, ampicillin/sulbactam and imipenem in Acinetobacter baumannii clinical isolates in Taiwan.
    Chiu CH; Lee HY; Tseng LY; Chen CL; Chia JH; Su LH; Liu SY
    Int J Antimicrob Agents; 2010 Apr; 35(4):382-6. PubMed ID: 20138741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and epidemiological features of an outbreak of acinetobacter infection in an intensive therapy unit.
    Crowe M; Towner KJ; Humphreys H
    J Med Microbiol; 1995 Jul; 43(1):55-62. PubMed ID: 7608957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].
    Zhao C; Xie W; Zhang W; Ye Z; Wu H
    Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of pan-drug resistant Acinetobacter baumannii.
    Lee CM; Lim HK; Liu CP; Tseng HK
    Scand J Infect Dis; 2005; 37(3):195-9. PubMed ID: 15849052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections.
    Baran G; Erbay A; Bodur H; Ongürü P; Akinci E; Balaban N; Cevik MA
    Int J Infect Dis; 2008 Jan; 12(1):16-21. PubMed ID: 17513154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emergence and spread of carbapenem-resistant strains of Acinetobacter baumannii in a tertiary-care hospital in Poland.
    Wroblewska MM; Towner KJ; Marchel H; Luczak M
    Clin Microbiol Infect; 2007 May; 13(5):490-6. PubMed ID: 17331123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clusters of imipenem-resistant Acinetobacter baumannii clones producing different carbapenemases in an intensive care unit.
    Tsakris A; Ikonomidis A; Poulou A; Spanakis N; Vrizas D; Diomidous M; Pournaras S; Markou F
    Clin Microbiol Infect; 2008 Jun; 14(6):588-94. PubMed ID: 18397334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology and impact of imipenem resistance in Acinetobacter baumannii.
    Lautenbach E; Synnestvedt M; Weiner MG; Bilker WB; Vo L; Schein J; Kim M
    Infect Control Hosp Epidemiol; 2009 Dec; 30(12):1186-92. PubMed ID: 19860563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
    Alişkan H; Colakoğlu S; Turunç T; Demiroğlu YZ; Erdoğan F; Akin S; Arslan H
    Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sulbactam efficacy in experimental models caused by susceptible and intermediate Acinetobacter baumannii strains.
    Rodríguez-Hernández MJ; Cuberos L; Pichardo C; Caballero FJ; Moreno I; Jiménez-Mejías ME; García-Curiel A; Pachón J
    J Antimicrob Chemother; 2001 Apr; 47(4):479-82. PubMed ID: 11266426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antibiotic resistance of Acinetobacter baumannii isolates: data from Ibni Sina Hospital for the year 2002].
    Akan OA
    Mikrobiyol Bul; 2003 Oct; 37(4):241-6. PubMed ID: 14748260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.